Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Gene L Colice. (2013) The misuse of asthma drugs. Expert Review of Respiratory Medicine 7:3, pages 307-320.
Read now
Read now
P Navaratnam, HS Friedman & E Urdaneta. (2010) The impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents. Patient Preference and Adherence 4, pages 197-205.
Read now
Read now
Howard S. Friedman$suffix/text()$suffix/text(), Prakash Navaratnam$suffix/text()$suffix/text() & John McLaughlin$suffix/text()$suffix/text(). (2010) Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma. Journal of Asthma 47:9, pages 994-1000.
Read now
Read now
Ceri Hirst, Brian Calingaert, Richard Stanford & Jordi Castellsague. (2010) Use of Long-Acting β-Agonists and Inhaled Steroids in Asthma: Meta-analysis of Observational Studies. Journal of Asthma 47:4, pages 439-446.
Read now
Read now
Prakash Navaratnam, Howard S. Friedman & Eduardo Urdaneta. (2009) Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges. Current Medical Research and Opinion 25:12, pages 2895-2901.
Read now
Read now
Xin Ye, Benjamin Gutierrez, Victoria Zarotsky, Michael Nelson & Christopher M. Blanchette. (2009) Appropriate use of inhaled corticosteroid and long-acting ß2-adrenergic agonist combination therapy among asthma patients in a US commercially insured population. Current Medical Research and Opinion 25:9, pages 2251-2258.
Read now
Read now
Gene L. Colice, Andrew P. Yu, Jasmina I. Ivanova, Matthew Hsieh, Howard G. Birnbaum, Maureen J. Lage & Corrine Brewster. (2008) Costs and Resource Use of Mild Persistent Asthma Patients Initiated on Controller Therapy. Journal of Asthma 45:4, pages 293-299.
Read now
Read now
Gene Colice, Eric Q. Wu, Howard Birnbaum, Maham Daher & B. Marynchenko Maryna. (2007) Use of Inhaled Corticosteroids and Healthcare Costs in Mild Persistent Asthma. Journal of Asthma 44:6, pages 479-483.
Read now
Read now
Articles from other publishers (14)
J. Bradford Rice, Alan G. White, Lauren M. Scarpati, George Wan & Winnie W. Nelson. (2017) Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clinical Therapeutics 39:11, pages 2216-2229.
Crossref
Crossref
Christian Jacob, Jennifer S. Haas, Benno Bechtel, Peter Kardos & Sebastian Braun. (2016) Assessing asthma severity based on claims data: a systematic review. The European Journal of Health Economics 18:2, pages 227-241.
Crossref
Crossref
Jing Hao, Rosa Rodriguez-Monguio & Enrique Seoane-Vazquez. (2015) Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals. PLOS ONE 10:10, pages e0140708.
Crossref
Crossref
Gimena Hernández, Mónica Avila, Àngels Pont, Olatz Garin, Jordi Alonso, Laurent Laforest, Christopher J Cates & Montserrat Ferrer. (2014) Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies. Respiratory Research 15:1.
Crossref
Crossref
Felicia C Allen-Ramey, Linda M Nelsen, Joseph B Leader, Dione Mercer, Henry Lester Kirchner & James B Jones. (2013) Electronic health record-based assessment of oral corticosteroid use in a population of primary care patients with asthma: an observational study. Allergy, Asthma & Clinical Immunology 9:1.
Crossref
Crossref
Prakash Navaratnam, Howard S. Friedman & Eduardo Urdaneta. (2011) Treatment with Inhaled Mometasone Furoate Reduces Short-Acting β2 Agonist Claims and Increases Adherence Compared to Fluticasone Propionate in Asthma Patients. Value in Health 14:2, pages 339-346.
Crossref
Crossref
D. Montani, A. Cavailles, L. Bertoletti, A. Botelho, A. Cortot, C. Taillé, S. Marchand-Adam, D. Pinot, C. Chouaid, B. Crestani, G. Garcia, M. Humbert, J.-P. L’huillier, A. Magnan, I. Tillie-Leblond & P. Chanez. (2010) Les exacerbations de l’asthme de l’adulte en questions. Revue des Maladies Respiratoires 27:10, pages 1175-1194.
Crossref
Crossref
Prakash Navaratnam, Eduardo Urdaneta, John McLaughlin & Howard S. Friedman. (2010) Incidence of Exacerbations and Hospitalizations Is Reduced and Time to Exacerbations Is Prolonged with Mometasone Furoate Dry Powder Inhaler Versus Beclomethasone Dipropionate Hydrofluoroalkane Aerosol in Patients with Mild Asthma. Health Outcomes Research in Medicine 1:2, pages e93-e102.
Crossref
Crossref
A. Vergnenègre, K. Atsou & C. Chouaïd. (2010) Pharmacoéconomie pour le pneumologue. EMC - Pneumologie 7:1, pages 1-15.
Crossref
Crossref
Chet Leach, Gene L. Colice & Allan Luskin. (2009) Particle size of inhaled corticosteroids: Does it matter?. Journal of Allergy and Clinical Immunology 124:6, pages S88-S93.
Crossref
Crossref
Howard S. Friedman, Nemr S. Eid, Simone Crespi, Teresa K. Wilcox & Gregory Reardon. (2009) Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations. Clinical Therapeutics 31:5, pages 1056-1063.
Crossref
Crossref
Hans Jürgen Hoffmann, Lars Peter Nielsen, Henrik Harving, John H. Heinig & Ronald Dahl. (2008) Asthmatics able to step down from inhaled corticosteroid treatment without loss of asthma control have low serum eotaxin/CCL11. The Clinical Respiratory Journal 2:3, pages 149-157.
Crossref
Crossref
Robert S. Zeiger, Joel W. Hay, Richard Contreras, Wansu Chen, Virginia P. Quinn, Brian Seal & Michael Schatz. (2008) Asthma costs and utilization in a managed care organization. Journal of Allergy and Clinical Immunology 121:4, pages 885-892.e5.
Crossref
Crossref
A. Vergnenègre, P. Godard, K. Atsou & C. Chouaïd. (2008) Les corticoïdes inhalés dans l’asthme : analyse médico-économique des essais cliniques. Revue des Maladies Respiratoires 25:4, pages 375-390.
Crossref
Crossref